Northwestern Mutual Wealth Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
Other funds holding XERS
RA
Northwestern Mutual Wealth Management's XERS Position: Q2 2026 in Review
Northwestern Mutual Wealth Management held its Xeris Biopharma Holdings (XERS) position steady in Q2 2026 at 2,789 shares worth $22.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2834.
Northwestern Mutual Wealth Management first reported a position in XERS in Q3 2021 and has held it in 8 quarters since. The position peaked at $63.4K in Q3 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.
- Northwestern Mutual Wealth Management held 2,789 shares of Xeris Biopharma Holdings worth $22.1K as of Q2 2026.
- Northwestern Mutual Wealth Management left its Xeris Biopharma Holdings share count unchanged in Q2 2026.
- Xeris Biopharma Holdings made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2834 holding.
- Northwestern Mutual Wealth Management first reported a position in Xeris Biopharma Holdings in Q3 2021 and has held it in 8 quarters since.
- Northwestern Mutual Wealth Management's Xeris Biopharma Holdings position peaked at $63.4K in Q3 2025.
- 240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.